BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 28964660)

  • 21. Shape and Enhancement Characteristics of Pancreatic Neuroendocrine Tumor on Preoperative Contrast-enhanced Computed Tomography May be Prognostic Indicators.
    Okabe H; Hashimoto D; Chikamoto A; Yoshida M; Taki K; Arima K; Imai K; Tamura Y; Ikeda O; Ishiko T; Uchiyama H; Ikegami T; Harimoto N; Itoh S; Yamashita YI; Yoshizumi T; Beppu T; Yamashita Y; Baba H; Maehara Y
    Ann Surg Oncol; 2017 May; 24(5):1399-1405. PubMed ID: 27896509
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Computed Tomography Features Predictive of Lymph Node Involvement in Patients With a Nonfunctioning Pancreatic Neuroendocrine Tumor.
    Choi SH; Kim HJ; Kim SY; Byun JH; Kim KW; Song KB; Kim SC; Kim MH
    Pancreas; 2017 Sep; 46(8):1056-1063. PubMed ID: 28787330
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Lymph Node Ratio-Based Staging Model Is Superior to the Current Staging System for Pancreatic Neuroendocrine Tumors.
    Gaitanidis A; Patel D; Nilubol N; Tirosh A; Kebebew E
    J Clin Endocrinol Metab; 2018 Jan; 103(1):187-195. PubMed ID: 29069375
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pancreatic neuroendocrine tumors: Correlation between the contrast-enhanced computed tomography features and the pathological tumor grade.
    Takumi K; Fukukura Y; Higashi M; Ideue J; Umanodan T; Hakamada H; Kanetsuki I; Yoshiura T
    Eur J Radiol; 2015 Aug; 84(8):1436-1443. PubMed ID: 26022520
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic Value of Lymph Node Status and Extent of Lymphadenectomy in Pancreatic Neuroendocrine Tumors Confined To and Extending Beyond the Pancreas.
    Conrad C; Kutlu OC; Dasari A; Chan JA; Vauthey JN; Adams DB; Kim M; Fleming JB; Katz MH; Lee JE
    J Gastrointest Surg; 2016 Dec; 20(12):1966-1974. PubMed ID: 27714644
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prediction of Pancreatic Neuroendocrine Tumor Grade Based on CT Features and Texture Analysis.
    Canellas R; Burk KS; Parakh A; Sahani DV
    AJR Am J Roentgenol; 2018 Feb; 210(2):341-346. PubMed ID: 29140113
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overestimated Oncologic Significance of Lymph Node Metastasis in G1 Nonfunctioning Neuroendocrine Tumor in the Left Side of the Pancreas.
    Yoo YJ; Yang SJ; Hwang HK; Kang CM; Kim H; Lee WJ
    Medicine (Baltimore); 2015 Sep; 94(36):e1404. PubMed ID: 26356692
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Outcomes of resected nonfunctional pancreatic neuroendocrine tumors: Do size and symptoms matter?
    Sallinen V; Haglund C; Seppänen H
    Surgery; 2015 Dec; 158(6):1556-63. PubMed ID: 26070847
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is the combination of MR and CT findings useful in determining the tumor grade of pancreatic neuroendocrine tumors?
    Toshima F; Inoue D; Komori T; Yoshida K; Yoneda N; Minami T; Matsui O; Ikeda H; Gabata T
    Jpn J Radiol; 2017 May; 35(5):242-253. PubMed ID: 28258323
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Accuracy and Prognostic Impact of Nodal Status on Preoperative Imaging for Management of Pancreatic Neuroendocrine Tumors: A Multi-Institutional Study.
    Zhang N; He J; Maithel SK; Poultsides G; Rocha F; Weber S; Fields R; Idrees K; Cho C; Lv Y; Zhang XF; Pawlik TM
    Ann Surg Oncol; 2024 May; 31(5):2882-2891. PubMed ID: 38097878
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Contrast-enhancement ratio on multiphase enhanced computed tomography predicts recurrence of pancreatic neuroendocrine tumor after curative resection.
    Arai T; Kobayashi A; Fujinaga Y; Yokoyama T; Shimizu A; Motoyama H; Kitagawa N; Notake T; Shirota T; Fukushima K; Masuo H; Kadoya M; Miyagawa S
    Pancreatology; 2016; 16(3):397-402. PubMed ID: 26850565
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The clinicopathologic and operative characteristics of patients with small nonfunctioning pancreatic neuroendocrine tumors.
    Ha S; Song KB; Hong S; Shin D; Park Y; Kwon J; Lee W; Jun E; Lee JH; Hwang DW; Kim SC
    ANZ J Surg; 2021 Jul; 91(7-8):E484-E492. PubMed ID: 34291544
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential diagnosis between pancreatic solid pseudopapillary tumors and pancreatic neuroendocrine tumors based on contrast enhanced ultrasound imaging features.
    Zhang Q; Qiu YJ; Yang DH; Lu XY; Chen S; Dong Y; Wang WP
    Clin Hemorheol Microcirc; 2023; 85(4):421-431. PubMed ID: 37718786
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic Value and Clinical Predictors of Lymph Node Metastases in Pancreatic Neuroendocrine Tumors.
    Zhang Z; Liu M; Ji S; Luo G; Xu W; Liu W; Hu Q; Sun Q; Ye Z; Qin Y; Fan G; Yu X; Xu X
    Pancreas; 2020 Mar; 49(3):381-386. PubMed ID: 32132507
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differentiation between non-hypervascular pancreatic neuroendocrine tumors and mass-forming pancreatitis using contrast-enhanced computed tomography.
    Wang Y; Chen X; Wang J; Cui W; Wang C; Chen X; Wang Z
    Acta Radiol; 2021 Feb; 62(2):190-197. PubMed ID: 32375515
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Application of low dose pancreas perfusion CT combined with enhancement scanning in diagnosis of pancreatic neuroendocrine tumors.
    Wan Y; Hao H; Meng S; Li Z; Yu F; Meng Chi ; Chao Q; Gao J
    Pancreatology; 2021 Jan; 21(1):240-245. PubMed ID: 33191144
    [TBL] [Abstract][Full Text] [Related]  

  • 37. What Is the Role of Lymph Node Resections in Small Islet Tumors?
    Gangi A; Ferrone CR
    Adv Surg; 2023 Sep; 57(1):47-58. PubMed ID: 37536861
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pancreatic neuroendocrine tumors (pNETs): the predictive value of MDCT characteristics in the differentiation of histopathological grades.
    Salahshour F; Mehrabinejad MM; Zare Dehnavi A; Alibakhshi A; Dashti H; Ataee MA; Ayoobi Yazdi N
    Abdom Radiol (NY); 2020 Oct; 45(10):3155-3162. PubMed ID: 31897681
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of contrast-enhanced computed tomography for the differential diagnosis of hypovascular pancreatic neuroendocrine tumors from chronic mass-forming pancreatitis.
    Ren S; Qian L; Daniels MJ; Duan S; Chen R; Wang Z
    Eur J Radiol; 2020 Dec; 133():109360. PubMed ID: 33126171
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of risk factors for recurrence after curative resection of well-differentiated pancreatic neuroendocrine tumors based on the new grading classification.
    Tsutsumi K; Ohtsuka T; Fujino M; Nakashima H; Aishima S; Ueda J; Takahata S; Nakamura M; Oda Y; Tanaka M
    J Hepatobiliary Pancreat Sci; 2014 Jun; 21(6):418-25. PubMed ID: 24142395
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.